Image-guided therapy
Ultra-low contrast PCI
Make low contrast a high priority for PCI procedures
With advanced Philips imaging and proven physiology technologies, learn how you can confidently treat PCI patients with less contrast.
Reduce need for contrast during PCI procedures to enhance patient care
During PCI procedures, angiograms aren't always accurate for diagnoses. The contrast dye used in these tests can harm the kidneys, leading to contrast-induced nephropathy (CIN) and hospital-acquired acute kidney injury (AKI).1The need to implement efficient workflows while delivering safe and effective treatment has never been greater.Read the latest publication
Philips offers an evolved solution of vascular imaging and physiology technologies
We provide clinicians with diagnostic and treatment options that not only optimize PCI procedures, but also reduce dependency on angiography and nephrotoxic imaging contrast.
Explore the broadest suite of integrated solutions for ultra-low contrast PCI procedures
- iFR co-registration: As an alternative or adjunct to IVUS Co-registration, iFR pullback can be co-registered onto the angiogram to assess both the degree and length of vessel stenosis.
- Dynamic Coronary Roadmap: This Philips-exclusive technology provides a real-time view of the coronary arteries and removes the need for additional contrast injections.
- StentBoost: This simple, quick and cost-effective tool enhances stent visualization in the coronary arteries.
Today’s advanced imaging and physiology technologies are enabling the delivery of precision PCI with much less imaging contrast than in the past, reducing the risk of AKI and opening the door to therapy in a group of patients commonly denied PCI.
Dr. Ziad Ali
St. Francis Hospital & Heart Center
Related procedures
Advance percutaneous coronary interventions with imaging solutions, IVUS and real-time fluoroscopy for precise diagnosis and treatment.
Footnotes
- Amin P, et al. Incremental cost of Acute Kidney Injury after Percutaneous Coronary Intervention in the United States. AM J Cardiol. 2020 Jan 1;125(1):29-331
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.